Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs.
Walch-Rückheim B, Pahne-Zeppenfeld J, Fischbach J, Wickenhauser C, Horn LC, Tharun L, Büttner R, Mallmann P, Stern P, Kim YJ, Bohle RM, Rübe C, Ströder R, Juhasz-Böss I, Solomayer EF, Smola S. Walch-Rückheim B, et al. Among authors: smola s. Cancer Res. 2016 Jul 1;76(13):3872-83. doi: 10.1158/0008-5472.CAN-14-1306. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216197
Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.
Sperling T, Ołdak M, Walch-Rückheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S. Sperling T, et al. Among authors: smola s. PLoS Pathog. 2012;8(7):e1002833. doi: 10.1371/journal.ppat.1002833. Epub 2012 Jul 26. PLoS Pathog. 2012. PMID: 22911498 Free PMC article.
Immune deviation and cervical carcinogenesis.
Smola S. Smola S. Papillomavirus Res. 2019 Jun;7:164-167. doi: 10.1016/j.pvr.2019.03.006. Epub 2019 Apr 10. Papillomavirus Res. 2019. PMID: 30980967 Free PMC article. Review.
Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse.
Theobald L, Stroeder R, Melchior P, Iordache II, Tänzer T, Port M, Glombitza B, Marx S, Schub D, Herr C, Hart M, Ludwig N, Meese E, Kim YJ, Bohle RM, Smola S, Rübe C, Solomayer EF, Walch-Rückheim B. Theobald L, et al. Among authors: smola s. Mol Oncol. 2021 Dec;15(12):3559-3577. doi: 10.1002/1878-0261.13095. Epub 2021 Sep 13. Mol Oncol. 2021. PMID: 34469022 Free PMC article.
129 results